These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Plasma prolidase activity: a possible index of collagen catabolism in chronic liver disease. Myara I, Myara A, Mangeot M, Fabre M, Charpentier C, Lemonnier A. Clin Chem; 1984 Feb; 30(2):211-5. PubMed ID: 6692525 [Abstract] [Full Text] [Related]
44. beta-Hexosaminidase activity in the acute phase of CCl4 poisoning in the rat. Antoniello S, Auletta M, Cerini R, Cacciatore F, Magri P. Enzyme; 1990 Feb; 43(3):151-4. PubMed ID: 2151317 [Abstract] [Full Text] [Related]
48. Establishment of a liver fibrosis model in cynomolgus monkeys. Ding K, Liu MR, Li J, Huang K, Liang Y, Shang X, Chen J, Mu J, Liu H. Exp Toxicol Pathol; 2014 Aug; 66(5-6):257-61. PubMed ID: 24751324 [Abstract] [Full Text] [Related]
49. Immunomodulatory effect of oxymatrine on induced CCl4-hepatic fibrosis in rats. Yu XH, Zhu JS, Yu HF, Zhu L. Chin Med J (Engl); 2004 Dec; 117(12):1856-8. PubMed ID: 15603720 [No Abstract] [Full Text] [Related]
53. Beta-hexosaminidase activity in alcoholic fatty liver and in CCl4-induced liver fibrosis of the rat. Antoniello S, Auletta M, Vatiero V, Nigro C, Cacciatore L. Enzyme; 1989 Dec; 42(2):68-72. PubMed ID: 2574105 [Abstract] [Full Text] [Related]
55. Characteristics of partially purified prolidase and prolinase from the human prostate. Masuda S, Watanabe H, Morioka M, Fujita Y, Ageta T, Kodama H. Acta Med Okayama; 1994 Aug; 48(4):173-9. PubMed ID: 7817771 [Abstract] [Full Text] [Related]
58. Characteristics of prolidase and prolinase in prolidase-deficient patients with some preliminary studies of their role in skin. Oono T, Arata J. J Dermatol; 1988 Jun; 15(3):212-9. PubMed ID: 3053830 [No Abstract] [Full Text] [Related]